A detailed history of Cutter Capital Management, LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 83,756 shares of SRPT stock, worth $10.2 Million. This represents 3.09% of its overall portfolio holdings.

Number of Shares
83,756
Previous 89,379 6.29%
Holding current value
$10.2 Million
Previous $14.1 Billion 25.93%
% of portfolio
3.09%
Previous 4.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$124.33 - $156.75 $699,107 - $881,405
-5,623 Reduced 6.29%
83,756 $10.5 Billion
Q2 2024

Aug 14, 2024

SELL
$113.33 - $163.85 $566,650 - $819,250
-5,000 Reduced 5.3%
89,379 $14.1 Billion
Q1 2024

May 15, 2024

BUY
$93.7 - $141.53 $8.84 Million - $13.4 Million
94,379 New
94,379 $12.2 Billion

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.7B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Cutter Capital Management, LP Portfolio

Follow Cutter Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutter Capital Management, LP with notifications on news.